This trend accentuates the company's continued capability to drive growth. Specifically, the three-year growth rate stands at 19.3, and the rate over the past five years is 15.9. Moreover, Charles River Laboratories International Inc has seen a robust increase in its earnings before interest, taxes, depreciation, and amortization (EBITDA) over the past few years. The company's 3-Year Revenue Growth Rate is 13.7%, which outperforms better than 58.54% of 205 companies in the Medical Diagnostics & Research industry. Ranked highly in Growth, Charles River Laboratories International Inc demonstrates a strong commitment to expanding its business. Charles River Laboratories International Inc's strong Predictability Rank of 5.0 stars out of five underscores its consistent operational performance, providing investors with increased confidence. From genetically standard and disease-specific models to surgically altered animals, you can.
We also offer study-ready knockout mouse models for in vivo studies through our collaboration with genOway. The company's Operating Margin has increased (11.96%) over the past five years, as shown by the following data: 2018: 14.62 2019: 13.40 2020: 14.80 2021: 16.66 2022: 16.37. Charles River is committed to providing you with high-quality animal models, including mice, rats, guinea pigs, hamsters, gerbils, and rabbits. The Profitability Rank shows Charles River Laboratories International Inc's impressive standing among its peers in generating profit. Unpacking the Investment Potential of Charles River Laboratories International Inc (CRL): A Deep Dive into Financial Metrics and Competitive Strengths Profitability Rank Breakdown With high ranks in profitability, growth, and GF value, and decent ranks in financial strength and momentum, GuruFocus assigned Charles River Laboratories International Inc the GF Score of 95 out of 100, which signals the highest outperformance potential. Thus, they are weighted differently when calculating the total score. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance.
The GF score is calculated using the five key aspects of analysis. The GF Score ranges from 0 to 100, with 100 as the highest rank.Ĭharles River Laboratories International Inc's GF Score components are as follows:Įach one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. Therefore, when picking stocks, investors should invest in companies with high GF Scores. According to federal reports, Charles River used 9,231 nonhuman primates in 2017 to test. The stocks with a higher GF Score generally generate higher returns than those with a lower GF Score. Charles River Laboratories is the second-largest importer of nonhuman primates into the U.S., bringing in thousands of monkeys who have been taken from their families in the wild or bred on decrepit monkey factory farms in China, Mauritius, and Vietnam. The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. Unpacking the Investment Potential of Charles River Laboratories International Inc (CRL): A Deep Dive into Financial Metrics and Competitive Strengths Understanding the GF Score
0 kommentar(er)
